Print this page
-
Long Term Follow Up for Subjects Treated with Gene Therapy Cell Products at Rutgers Cancer Institute.
Protocol: 192103Principal Investigator:
- Christian Hinrichs (Rutgers University)
Applicable Disease Sites: Any Site -
Choices About Genetic Testing And Learning Your Risk with Smart Technology (CATALYST)
Protocol: 132307Principal Investigator:
- Anita Kinney PhD,RN (Rutgers University)
Applicable Disease Sites: Pancreas
Other Female Genital
Prostate
Colon
Ovary
Breast -
New Jersey Firefighters Cancer Prevention Study: Toms River.
Protocol: 131904Principal Investigator:
- Judith Graber (Archived - School of Public Health)
Applicable Disease Sites: Any Site -
Evaluating the Post-Treatment Care Experience of Cancer Survivors.
Protocol: 131910Principal Investigator:
- Sharon Manne PhD (Rutgers University)
Applicable Disease Sites: Any Site -
Concordance of Self-reported Race and Ethnicity with Hospital Records Among Pediatric Patients.
Protocol: 112001Principal Investigator:
- Peter Cole M.D. (Rutgers University)
Applicable Disease Sites: Any Site -
Improving Chemotherapy-Induced Nausea Control Through Bright Ideas?-CIN Training: A Feasibility Study in Children Receiving Oral Chemotherapy.
Protocol: 132104Principal Investigator:
- Katie Devine (Rutgers University)
Applicable Disease Sites: Leukemia, other
Leukemia, not otherwise specified